The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.
Dear friends, dear colleagues,
It has been our pleasure to greet many of you at theSeventh International Working Conference of Pharmaceutical Care Network Europe entitled "Does Pharmaceutical Care Impact on the Safety of Individual Patients?"
The conference has been a success, not only from a scientific viewpoint, but also socially.
PCNE strongly believes that to develop high quality research and to design or deliver effective pharmaceutical care interventions, you need to continually update yourself, exchange expertise and experience with colleagues in the same research field. This conference was developed for you to do so, whether you work in education, in industry, as a practitioner or as a researcher. You can find reports and lectures of this conference by clicking on one of the tabs above.
Dr. Mary Tully, Chairperson
Dr. Maria Cordina, Conference Secretary
Health care in western countries has taken a dramatic turn within the last 20-30 years. During this period of time free market mechanisms have become the guiding principle of health care policy, organization, delivery and evaluation. In the midst of change stand the patients, who are increasingly seen as someone who wants to participate in, if not control, the medical decision-making processes - as so called 'consumers'. This portrayal of patients as consumers is said to hold true, in particular, for patients who manage a chronic illness/condition, but has also been criticized for not paying sufficient attention to patients' views and experiences, among others; their perspectives on conventional medicines. The talk will discuss findings from a study that set out to explore how individuals who medically manage their own, or their child's atopic dermatitis, perceive conventional medicines and health care professionals - incl. community pharmacy staff. Study findings will be presented that nuance the portrayal of patients as consumers. The talk is aimed at persons who research, design and practice pharmaceutical services in community pharmacy.
In the changing context of healthcare - standards, quality, targets, evidence - we need to develop a coherent and consistent way of recording our activities and contributions to patient care in a way that is more transparent and creates an entry into the patient record that is visible to all.
This lecture will consider the experience of reviewing pharmacy documentation and recording in the UK as a result of the implementation of electronic patient records.
Workshop facilitators:Dr. Carmel Hughes (N. Ireland) and Dr. Nina Griese (Germany)
This workshop introduced the novice researcher to the key elements of setting up intervention studies in community pharmacy practice. Formulating research questions, selection of appropriate data collection methods, pitfalls to be avoided, and consideration of the necessary research team members were explored in this workshop. The role of other types of research methodologies (e.g. qualitative methods) wasl also considered.
Workshop facilitators: Dr. Ines Krass (Australia) and Dr. Charlotte Rossing (Denmark)
Description:This workshop commenced with presentations by workshop leaders drawing on their experiences in the development and evaluation of several pharmaceutical care programs. The presentationhighlighted the different stages in process; use of development projects and qualitative research to inform components of the intervention; selection and application of theoretical frameworks, pilot testing, implementation and design of an evaluation strategy.
In addition, the presentations will covered the formulation of relevant research questions, selection of appropriate research designs and outcome measures to answer the questions, the design of care protocols and approaches to data collection. Participants worked in two groups to identify a target population, design protocols for care delivery and a research design using both process evaluations and the principles of the ECHO model (economic, clinical and humanistic outcomes).
Workshop facilitators: Prof. Dr. Marcel Bouvy (Netherlands) and Prof. Dr. Kurt Hersberger (Switzerland)
This workshop discussed how to measure individualised patient safety, concentrating on quality indicators and the perception of safety by patients.
Workshop facilitators: Ms. Ann Slee (United Kingdom) and Dr. Veerle Foulon (Belgium)
This workshop explored the use of multidisciplinary patient records for documentation in pharmaceutical care service and research. It incudedissues such as what pharmacists should record, and differences between documentation in paper and electronic records. It resulted in a paper that oulined the requirements for a pharmaceutical care records within a general health documentation system.
Board Number: 1
Board Number: 2
Board Number: 3
Board Number: 4
Board Number: 5
Board Number: 6
Board Number: 7
Board Number: 8
Board Number: 9
Board Number: 10
Board Number: 11
Board Number: 12
Board Number: 13
Board Number: 14
Board Number: 15
Board Number: 16
Board Number: 17